Each capsule of Broncho-Vaxom® Adults contains: Lyophilized Bacterial Lysates of: Haemophilus influenzae; Diplococcus pneumoniae; Klebsiella pneumoniae and ozaenae; Staphylococcus aureus; Streptococcus pyogenes and viridans; Neisseria catarrhalis 7 mg; Excipients q.s.;
Therapeutic Action:
Immunostimulant agent.
Indications:
Immunotherapy. Prevention of recurrent infections of the respiratory tract and acute infectious exacerbations of chronic bronchitis. Adjuvant treatment of acute respiratory tract infections.
Dosage:
Êpsules: Preventive and/or consolidation therapy: 1 capsule daily administered on an empty stomach for 10 consecutive days per month for a total period of 3 months.
Treatment of acute episodes: 1 capsule daily administered on an empty stomach until symptoms disappear (minimum 10 days). When treatment requires the simultaneous administration of antibiotics, the combination with Broncho-Vaxom® is recommended from the beginning of therapy.
